Cefuroxime Axetil Tablet, Film Coated
Product Images NDC 67877-216

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cefuroxime Axetil (NDC 67877-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefuroxime 250 mg 20tab

Cefuroxime 250 mg 20tab
Sea package insert for Cefuroxime Axetil Tablets, USP 250 mg dosage. The package should be stored within the designated temperature range, and the label should be kept intact. Replace the cap securely after opening and dispense in closed containers. The text also includes the NDC and a reference to ASCEND.*
FDA Label Image

Cefuroxime 500 mg 60tab

Cefuroxime 500 mg 60tab
Each tablet contains cefuroxime axetil USP equivalent to 500 mg of cefuroxime. This is a package insert for Dosage and Administration. Store at 20°C to 25°C (68°F to 77°F) and dispense in well-closed containers. Manufactured by Alkem Laboratories Ltd, India and Distributed by Ascend Laboratories, Parsippany, NJ 07054. It is a prescription-only medicine in the form of tablets. The product code is DDDRUGSDOIZS1, with NDC 67877-216-60. There is some unreadable text at the end.*
FDA Label Image
FDA Label Image

Cefuroxime-structure (Cefuroxime Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.